Active — Not RecruitingNot Applicable

Post Market Clinical Evaluation of Clareon PanOptix Pro and Clareon PanOptix Pro Toric IOLs

United States110 participantsStarted 2025-10-14

Plain-language summary

The purpose of this study is to collect safety and performance data on two approved intraocular lenses (IOLs). This study will be conducted in participants who require cataract surgery in both eyes. The IOLs are designed to provide vision at far, arm's length, and near.

Who can participate

Age range22 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Key Inclusion Criteria: * Subjects with cataracts in both eyes, planned for removal by routine surgery (phacoemulsification); * Subject must be able to understand and sign an approved informed consent form; * Subject is willing to complete all the required study visits for the duration of the study; * Other protocol-defined inclusion criteria may apply. Key Exclusion Criteria: * Ocular conditions as specified in the protocol; * Subjects who desire monovision correction; * Previous intraocular or corneal surgery; * Other protocol-defined exclusion criteria may apply.

What they're measuring

Mean Binocular Photopic Best Corrected Distance Visual Acuity (BCDVA)

Timeframe: Month 1 and Month 6 postoperative

Trial details

NCT IDNCT07161635

SponsorAlcon Research

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2026-10

View on ClinicalTrials.gov More Aphakia trials